Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal

Health

Pfizer To Acquire Obesity Drug Start-Up Metsera In $10 Billion Deal

By The New York Times

The obesity drug developer Metsera said on Friday that it had agreed to a deal to be acquired by Pfizer, which had been locked in a bidding war for the company with Novo Nordisk, the Danish maker of the weight-loss treatments Ozempic and Wegovy. Pfiz ...Read more

Related Posts

Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic

Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic

Nov 06, 2025
Patrick Mahomes Makes Demand After Chiefs’ Loss to Bills

Patrick Mahomes Makes Demand After Chiefs’ Loss to Bills

Nov 03, 2025
CFP rankings aren’t proof SEC lobbying worked - winning games was

CFP rankings aren’t proof SEC lobbying worked - winning games was

Nov 05, 2025
Nearly 400,000 people are starving in Sudan, a new report finds.

Nearly 400,000 people are starving in Sudan, a new report finds.

Nov 03, 2025
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.